JPRN-jRCT2011200017已完成2 期
A Phase II/III, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-Center Study to Evaluate the Efficacy and Safety of nemolizumab in Japanese Prurigo nodularis Patients with moderate to severe pruritus
ishiura Tomoyuki0 个研究点目标入组 210 人开始时间: 2020年12月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 13age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Prurigo nodularis with moderate or severe pruritus
排除标准
- •-Patients with immune deficiency
- •-Patients with body weight less than 30.0kg
- •-Patients with Hepatitis B virus or hepatitis C virus infection
- •-Patients with Evidence of tuberculosis (TB) infection
- •-Pregnant or lactating women.
研究者
相似试验
招募中
1 期
A Study of Tiragolumab in Combination with Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Patients with Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Canceron-squamous non-small cell lung cancer (NSCLC)MedDRA version: 20.0Level: LLTClassification code: 10079440Term: Non-squamous non-small cell lung cancer Class: 10029104CTIS2022-502031-20-00F. Hoffmann-La Roche AG500
进行中（未招募）
不适用
A Phase II/III, Double-Blind, Randomized, Placebo-Controlled, Multicenter, International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients with EmphysemaEUCTR2008-005326-36-DEKamada Limited200
进行中（未招募）
1 期
A clinical trial looking at the safety and effectiveness of a new drug forinhalation, looking to treat Alpha-1 Antitrypsin Deficient Patients withEmphysema.Alpha-1 Antitrypsin deficiency in patients with emphysema.MedDRA version: 17.1Level: PTClassification code 10001806Term: Alpha-1 anti-trypsin deficiencySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2008-005326-36-NLKamada Limited168
进行中（未招募）
1 期
A clinical trial looking at the safety and effectiveness of a new drug for inhalation, looking to treat Alpha-1 Antitrypsin Deficient Patients with Emphysema.Alpha-1 Antitrypsin deficiency in patients with emphysema.MedDRA version: 17.0 Level: PT Classification code 10001806 Term: Alpha-1 anti-trypsin deficiency System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2008-005326-36-GBKamada Limited168
进行中（未招募）
1 期
A clinical trial looking at the safety and effectiveness of a new drug forinhalation, looking to treat Alpha-1 Antitrypsin Deficient Patients withEmphysema.Alpha-1 Antitrypsin deficiency in patients with emphysema.MedDRA version: 17.0Level: PTClassification code 10001806Term: Alpha-1 anti-trypsin deficiencySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2008-005326-36-DKKamada Limited200